| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |